Richelle Candice Charles

The Identification of Enteric Fever-Specific Antigens for Population-Based Serosurveillance.

Mylona E, Hefele L, Tran Vu Thieu N, Trinh Van T, Nguyen Ngoc Minh C, Tran Tuan A, Karkey A, Dongol S, Basnyat B, Voong Vinh P, Ho Ngoc Dan T, Russell P, Charles RC, Parry CM, Baker S.

J Infect Dis. 2024 Mar 14. 229(3):833-844. PMID: 37403670

Cholera toxin and O-specific polysaccharide immune responses after oral cholera vaccination with Dukoral in different age groups of Bangladeshi participants.

Dash P, Hakim A, Akter A, Banna HA, Kaisar MH, Aktar A, Jahan SR, Ferdous J, Basher SR, Kamruzzaman M, Chowdhury F, Akter A, Tauheed I, Weil AA, Charles RC, Calderwood SB, Ryan ET, LaRocque RC, Harris JB, Bhuiyan TR, Qadri F.

mSphere. 2024 Mar 26. 9(3):e0056523. PMID: 38391226

Typhoid fever.

Meiring JE, Khanam F, Basnyat B, Charles RC, Crump JA, Debellut F, Holt KE, Kariuki S, Mugisha E, Neuzil KM, Parry CM, Pitzer VE, Pollard AJ, Qadri F, Gordon MA.

Nat Rev Dis Primers. 2023 Dec 14. 9(1):71. PMID: 38097589

T cell responses to SARS-CoV-2 infection and vaccination are elevated in B cell deficiency and reduce risk of severe COVID-19.

Zonozi R, Walters LC, Shulkin A, Naranbhai V, Nithagon P, Sauvage G, Kaeske C, Cosgrove K, Nathan A, Tano-Menka R, Gayton AC, Getz MA, Senjobe F, Worrall D, Iafrate AJ, Fromson C, Montesi SB, Rao DA, Sparks JA, Wallace ZS, Farmer JR, Walker BD, Charles RC, Laliberte K, Niles JL, Gaiha GD.

Sci Transl Med. 2023 11 29. 15(724):eadh4529. PMID: 38019932

Vaccination of Rabbits with a Cholera Conjugate Vaccine Comprising O-Specific Polysaccharide and a Recombinant Fragment of Tetanus Toxin Heavy Chain Induces Protective Immune Responses against Vibrio cholerae O1.

Kelly M, Jeon S, Yun J, Lee B, Park M, Whang Y, Lee C, Charles RC, Bhuiyan TR, Qadri F, Kamruzzaman M, Cho S, Vann WF, Xu P, Kovác P, Ganapathy R, Lynch J, Ryan ET.

Am J Trop Med Hyg. 2023 11 01. 109(5):1122-1128. PMID: 37783453

Seroprevalence of Vibrio cholerae in Adults, Haiti, 2017.

Matias WR, Guillaume Y, Augustin GC, Vissieres K, Ternier R, Charles RC, Harris JB, Franke MF, Ivers LC.

Emerg Infect Dis. 2023 09. 29(9):1929-1932. PMID: 37610182

Comparison of O-specific polysaccharide responses in patients following infection with Vibrio cholerae O139 versus vaccination with a bivalent (O1/O139) oral killed cholera vaccine in Bangladesh.

Kaisar MH, Kelly M, Kamruzzaman M, Bhuiyan TR, Chowdhury F, Khan AI, LaRocque RC, Calderwood SB, Harris JB, Charles RC, Cížová A, Mecárová J, Korcová J, Bystrický S, Kovác P, Xu P, Qadri F, Ryan ET.

mSphere. 2023 10 24. 8(5):e0025523. PMID: 37646517

Development of Shigella conjugate vaccines targeting Shigella flexneri 2a and S. flexneri 3a using a simple platform-approach conjugation by squaric acid chemistry.

Kelly M, Mandlik A, Charles RC, Verma S, Calderwood SB, Leung DT, Biswas R, Islam K, Kamruzzaman M, Chowdhury F, Khanam F, Vann WF, Khan AI, Bhuiyan TR, Qadri F, Vortherms AR, Kaminski R, Kovác P, Xu P, Ryan ET.

Vaccine. 2023 07 31. 41(34):4967-4977. PMID: 37400283

Seroepidemiology for Enteric Fever: Emerging Approaches and Opportunities.

Aiemjoy K, Seidman JC, Charles RC, Andrews JR.

Open Forum Infect Dis. 2023 May. 10(Suppl 1):S21-S25. PMID: 37274530

Shigella O-specific polysaccharide functional IgA responses mediate protection against shigella infection in an endemic high-burden setting.

Bernshtein B, Kelly M, Cizmeci D, Zhiteneva JA, Macvicar R, Kamruzzaman M, Bhuiyan TR, Chowdhury F, Khan AI, Qadri F, Charles RC, Xu P, Kovác P, Kaminski RW, Alter G, Ryan ET.

bioRxiv. 2023 May 05. PMID: 37205407